SMTL ID : 1r10.3 (2 other biounits)

Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain one (NBD1) with ATP, I4122 space group

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

homo-octamer

Ligands

8 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 4 residues within 4Å: Chain A: T.78, Q.106, D.185 Ligands: ATP.2 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:T.78 MG.5: 4 residues within 4Å: Chain B: T.78, Q.106, D.185 Ligands: ATP.6 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:T.78 MG.8: 4 residues within 4Å: Chain C: T.78, Q.106, D.185 Ligands: ATP.9 1 PLIP interactions: 1 interactions with chain C Metal complexes: C:T.78 MG.12: 4 residues within 4Å: Chain D: T.78, Q.106, D.185 Ligands: ATP.13 1 PLIP interactions: 1 interactions with chain D Metal complexes: D:T.78 MG.15: 4 residues within 4Å: Chain E: T.78, Q.106, D.185 Ligands: ATP.16 1 PLIP interactions: 1 interactions with chain E Metal complexes: E:T.78 MG.19: 4 residues within 4Å: Chain F: T.78, Q.106, D.185 Ligands: ATP.20 1 PLIP interactions: 1 interactions with chain F Metal complexes: F:T.78 MG.22: 4 residues within 4Å: Chain G: T.78, Q.106, D.185 Ligands: ATP.23 1 PLIP interactions: 1 interactions with chain G Metal complexes: G:T.78 MG.26: 4 residues within 4Å: Chain H: T.78, Q.106, D.185 Ligands: ATP.27 1 PLIP interactions: 1 interactions with chain H Metal complexes: H:T.78

8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.2: 14 residues within 4Å: Chain A: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106 Chain H: M.111 Ligands: MG.1 13 PLIP interactions: 13 interactions with chain A Hydrogen bonds: A:G.74, A:G.74, A:S.75, A:G.76, A:G.76, A:K.77, A:T.78, A:S.79, A:Q.106, A:Q.106 Salt bridges: A:K.77, A:K.77 pi-Stacking: A:F.43 ATP.6: 14 residues within 4Å: Chain A: M.111 Chain B: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106 Ligands: MG.5 11 PLIP interactions: 11 interactions with chain B Hydrogen bonds: B:E.23, B:G.74, B:S.75, B:G.76, B:G.76, B:K.77, B:T.78, B:S.79 Salt bridges: B:K.77, B:K.77 pi-Stacking: B:F.43 ATP.9: 14 residues within 4Å: Chain C: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106 Chain F: M.111 Ligands: MG.8 13 PLIP interactions: 13 interactions with chain C Hydrogen bonds: C:G.74, C:G.74, C:S.75, C:G.76, C:G.76, C:K.77, C:T.78, C:S.79, C:Q.106, C:Q.106 Salt bridges: C:K.77, C:K.77 pi-Stacking: C:F.43 ATP.13: 14 residues within 4Å: Chain C: M.111 Chain D: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106 Ligands: MG.12 13 PLIP interactions: 13 interactions with chain D Hydrogen bonds: D:E.23, D:E.23, D:T.73, D:G.74, D:S.75, D:G.76, D:G.76, D:K.77, D:T.78, D:S.79 Salt bridges: D:K.77, D:K.77 pi-Stacking: D:F.43 ATP.16: 14 residues within 4Å: Chain D: M.111 Chain E: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106 Ligands: MG.15 14 PLIP interactions: 14 interactions with chain E Hydrogen bonds: E:G.74, E:G.74, E:S.75, E:G.76, E:G.76, E:K.77, E:T.78, E:T.78, E:S.79, E:Q.106, E:Q.106 Salt bridges: E:K.77, E:K.77 pi-Stacking: E:F.43 ATP.20: 14 residues within 4Å: Chain E: M.111 Chain F: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106 Ligands: MG.19 11 PLIP interactions: 11 interactions with chain F Hydrogen bonds: F:E.23, F:G.74, F:S.75, F:G.76, F:G.76, F:K.77, F:T.78, F:S.79 Salt bridges: F:K.77, F:K.77 pi-Stacking: F:F.43 ATP.23: 14 residues within 4Å: Chain B: M.111 Chain G: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106 Ligands: MG.22 13 PLIP interactions: 13 interactions with chain G Hydrogen bonds: G:G.74, G:G.74, G:S.75, G:G.76, G:G.76, G:K.77, G:T.78, G:S.79, G:Q.106, G:Q.106 Salt bridges: G:K.77, G:K.77 pi-Stacking: G:F.43 ATP.27: 14 residues within 4Å: Chain G: M.111 Chain H: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106 Ligands: MG.26 13 PLIP interactions: 13 interactions with chain H Hydrogen bonds: H:E.23, H:E.23, H:T.73, H:G.74, H:S.75, H:G.76, H:G.76, H:K.77, H:T.78, H:S.79 Salt bridges: H:K.77, H:K.77 pi-Stacking: H:F.43

12 x ACY: ACETIC ACID(Non-functional Binders)

ACY.3: 5 residues within 4Å: Chain A: L.154, G.155, G.158, V.159, T.160 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:G.155, A:V.159, A:T.160 ACY.4: 6 residues within 4Å: Chain A: D.142, K.145, S.162, Q.165 Chain D: K.145, Q.165 4 PLIP interactions: 2 interactions with chain D, 2 interactions with chain A Hydrogen bonds: D:Q.165, A:S.162 Salt bridges: D:K.145, A:K.145 ACY.7: 7 residues within 4Å: Chain B: L.154, G.155, G.158, V.159, T.160, L.161 Chain C: L.191 6 PLIP interactions: 1 interactions with chain C, 5 interactions with chain B Hydrophobic interactions: C:L.191 Hydrogen bonds: B:G.155, B:V.159, B:T.160, B:T.160, B:L.161 ACY.10: 5 residues within 4Å: Chain C: L.154, G.155, G.158, V.159, T.160 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:G.155, C:V.159, C:T.160 ACY.11: 6 residues within 4Å: Chain B: K.145, Q.165 Chain C: D.142, K.145, S.162, Q.165 4 PLIP interactions: 2 interactions with chain C, 2 interactions with chain B Hydrogen bonds: C:S.162, B:Q.165 Salt bridges: C:K.145, B:K.145 ACY.14: 7 residues within 4Å: Chain A: L.191 Chain D: L.154, G.155, G.158, V.159, T.160, L.161 6 PLIP interactions: 5 interactions with chain D, 1 interactions with chain A Hydrogen bonds: D:G.155, D:V.159, D:T.160, D:T.160, D:L.161 Hydrophobic interactions: A:L.191 ACY.17: 5 residues within 4Å: Chain E: L.154, G.155, G.158, V.159, T.160 3 PLIP interactions: 3 interactions with chain E Hydrogen bonds: E:G.155, E:V.159, E:T.160 ACY.18: 6 residues within 4Å: Chain E: D.142, K.145, S.162, Q.165 Chain H: K.145, Q.165 4 PLIP interactions: 2 interactions with chain H, 2 interactions with chain E Hydrogen bonds: H:Q.165, E:S.162 Salt bridges: H:K.145, E:K.145 ACY.21: 7 residues within 4Å: Chain F: L.154, G.155, G.158, V.159, T.160, L.161 Chain G: L.191 6 PLIP interactions: 1 interactions with chain G, 5 interactions with chain F Hydrophobic interactions: G:L.191 Hydrogen bonds: F:G.155, F:V.159, F:T.160, F:T.160, F:L.161 ACY.24: 5 residues within 4Å: Chain G: L.154, G.155, G.158, V.159, T.160 3 PLIP interactions: 3 interactions with chain G Hydrogen bonds: G:G.155, G:V.159, G:T.160 ACY.25: 6 residues within 4Å: Chain F: K.145, Q.165 Chain G: D.142, K.145, S.162, Q.165 4 PLIP interactions: 2 interactions with chain F, 2 interactions with chain G Hydrogen bonds: F:Q.165, G:S.162 Salt bridges: F:K.145, G:K.145 ACY.28: 7 residues within 4Å: Chain E: L.191 Chain H: L.154, G.155, G.158, V.159, T.160, L.161 6 PLIP interactions: 5 interactions with chain H, 1 interactions with chain E Hydrogen bonds: H:G.155, H:V.159, H:T.160, H:T.160, H:L.161 Hydrophobic interactions: E:L.191

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lewis, H.A. et al., Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. Embo J. (2004)

Release Date

2003-12-09

Peptides

Cystic fibrosis transmembrane conductance regulator: ABCDEFGH

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

E
A

F
B

G
A

H
B

Cystic fibrosis transmembrane conductance regulator

Related Entries With Identical Sequence